Biopsy misidentification identified by DNA profiling in a large multicenter trial

Journal of Clinical Oncology

Volumn 29, Issue 13, 2011, Pages 1744-1749

  Marberger, Michael ^a,b,c,d,e   McConnell, John D ^a,b,c,d,e   Fowler, Ivy ^a,b,c,d,e   Andriole, Gerald L ^a,b,c,d,e   Bostwick, David G ^a,b,c,d,e   Somerville, Matthew C ^a,b,c,d,e   Rittmaster, Roger S ^a,b,c,d,e  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c GLAXOSMITHKLINE   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e BOSTWICK LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; DUTASTERIDE; PLACEBO;

ARTICLE; BIOPSY MISIDENTIFICATION; BLOOD SAMPLING; CLINICAL LABORATORY; CLINICAL PROTOCOL; CLINICAL RESEARCH; CONTROLLED STUDY; DIAGNOSTIC ERROR; DNA DETERMINATION; DNA FINGERPRINTING; DOUBLE BLIND PROCEDURE; HUMAN; HUMAN TISSUE; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; SAMPLING ERROR;

AZASTEROIDS; BIOPSY; DNA FINGERPRINTING; HUMANS; MALE; MEDICAL ERRORS; PROSTATIC NEOPLASMS; SPECIMEN HANDLING;

EID: 79955588025     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.32.1646     Document Type: Article

References (8)

1. Goldstein NS, Bégin LR, Grody WW, et al: Minimal or no cancer in radical prostatectomy specimens: Report of 13 cases of the "vanishing cancer phenomenon." Am J Surg Pathol 19:1002-1009, 1995
2. Andriole G, Bostwick D, Brawley O, et al: Chemoprevention of prostate cancer in men at high risk: Rationale and design of the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) trial. J Urol 172:1314-1317, 2004 (Pubitemid 39249705)
3. Kimpton CP, Gill P, Walton A, et al: Automated DNA profiling employing multiplex amplification of short tandem repeat loci. PCR Methods Appl 3:13-22, 1993 (Pubitemid 23256635)
4. Andriole GL, Bostwick DG, Brawley OW, et al: Effect of dutasteride on the risk of prostate cancer. N Engl J Med 362:1192-1202, 2010
5. DiGiuseppe JA, Sauvageot J, Epstein JI: Increasing incidence of minimal residual cancer in radical prostatectomy specimens. Am J Surg Pathol 21:174-178, 1997 (Pubitemid 27084056)
6. Cao D, Hafez M, Berg K, et al: Little or no residual prostate cancer at radical prostatectomy: Vanishing cancer or switched specimen? A microsatellite analysis of specimen identity. Am J Surg Pathol 29:467-473, 2005 (Pubitemid 40411177)
7. Trpkov K, Gao Y, Hay R, et al: No residual cancer on radical prostatectomy after positive 10-core biopsy: Incidence, biopsy findings, and DNA specimen identity analysis. Arch Pathol Lab Med 130:811-816, 2006 (Pubitemid 43887000)
8. Mazzucchelli R, Barbisan F, Tagliabracci A, et al: Search for residual prostate cancer on pT0 radical prostatectomy after positive biopsy. Virchows Arch 450:371-378, 2007 (Pubitemid 46466384)